Exp Clin Endocrinol Diabetes 2012; 120(09): 547-552
DOI: 10.1055/s-0032-1323738
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Changes in Body Weight, Glucose Homeostasis, Lipid Profiles, and Metabolic Syndrome after Restrictive Bariatric Surgery

V. T. To
1   Medical Department II – Grosshadern, Ludwig-Maximilians University Munich, Germany
T. P. Hüttl
2   Department of Surgery – Grosshadern, Ludwig-Maximilians University Munich, Germany
3   Surgical Clinic, Bogenhausen, Munich, Germany
R. Lang
2   Department of Surgery – Grosshadern, Ludwig-Maximilians University Munich, Germany
K. Piotrowski
1   Medical Department II – Grosshadern, Ludwig-Maximilians University Munich, Germany
K. G. Parhofer
1   Medical Department II – Grosshadern, Ludwig-Maximilians University Munich, Germany
› Author Affiliations
Further Information

Publication History

received 24 February 2012
first decision 25 July 2012

accepted 15 August 2012

Publication Date:
15 October 2012 (online)



Bariatric surgery is an established therapy for morbid obesity. We evaluated the effects of sleeve-gastrectomy on weight, glucose and lipid metabolism and prevalence of metabolic-syndrome for up to 2 years.


In 52 morbidly obese patients weight, BMI, total-cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, Lipoprotein(a), glucose, HbA1c, insulin, and criteria defining the metabolic-syndrome were determined preoperatively and 6 (n=52), 12 (n=41) and 24 (n=5) months after surgery.


BMI decreased from 51±8 kg/m² to 40±7, 39±8, and 38±9 kg/m² at 6, 12, and 24 months postoperatively. Glucose and HbA1c changed from 116±44 to 93±21 and 94±18 mg/dl and 6.0±1.3 to 5.4±0.8 and 5.4±0.8% at 6 and 12 months postoperatively. Triglycerides decreased from 159±87 to 116±41 and 116±62 mg/dl, while HDL-­cholesterol increased from 46±12 to 50±12 and 56±13 mg/dl at 6 and 12 months. None of the changes correlated with changes in weight. Prevalence of metabolic syndrome decreased from 81% to 36% and 34% at 6 and 12 months, with individual criteria (central obesity, triglycerides, HDL-cholesterol, hypertension, and fasting glucose) being reduced by 8/12%, 31/28%, 12/37%, 27/30%, and 38/31% at 6/12 months, respectively. The decrease in triglycerides and HbA1c was more pronounced in hypertriglyceridemic patients compared to normo-triglyceridemic patients, while there was no significant difference between diabetic and non-diabetic patients.


This is the first study evaluating sleeve-gastrectomy in German patients. Our data indicate that sleeve-gastrectomy induces a similar metabolic improvement as malabsorptive surgery. Although metabolic improvement did not correlate with weight reduction, improvement almost exclusively occurred within the first 6 months, when significant weight reduction occurred. It is unclear whether this relates to the operative techniques or to the selection of patients.

  • References

  • 1 Finucane MM, Stevens GA, Cowan MJ et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557-567
  • 2 Field AE, Coakley EH, Must A et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001; 161: 1581-1586
  • 3 Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197-1209
  • 4 Xu WL, Atti AR, Gatz M et al. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 2011; 76: 1568-1574
  • 5 Chan JC, Cheung JC, Stehouwer CD et al. The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome – an analysis by structural equation modelling. Int J Obes Relat Metab Disord 2002; 26: 994-1008
  • 6 Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55: 615S-619S
  • 7 Huttl TP, Obeidat FW, Parhofer KG et al. Operative techniques and outcomes in metabolic surgery: sleeve gastrectomy. Zentralbl Chir 2009; 134: 24-31
  • 8 Karmali S, Johnson Stoklossa C, Sharma A et al. Bariatric surgery: a primer. Can Fam Physician 2010; 56: 873-879
  • 9 Schauer PR, Burguera B, Ikramuddin S et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003; 238: 467-484 discussion 484–485
  • 10 Ballantyne GH, Farkas D, Laker S et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg 2006; 16: 1189-1197
  • 11 Couzin J. Medicine. Bypassing medicine to treat diabetes. Science 2008; 320: 438-440
  • 12 Monteiro Junior FC, Silva Junior WS, Salgado Filho N et al. Effects of weight loss induced by bariatric surgery on the prevalence of metabolic syndrome. Arq Bras Cardiol 2009; 92: 418-422 35–39, 52–56
  • 13 Batsis JA, Romero-Corral A, Collazo-Clavell ML et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc 2008; 83: 897-907
  • 14 Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009. 120. 1640-1645
  • 15 McAuley KA, Williams SM, Mann JI et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001; 24: 460-464
  • 16 Behrens C, Tang BQ, Amson BJ. Early results of a Canadian laparoscopic sleeve gastrectomy experience. Can J Surg 2011; 54: 138-143
  • 17 Snyder B, Wilson T, Mehta S et al. Past, present, and future: Critical analysis of use of gastric bands in obese patients. Diabetes Metab Syndr Obes 2010; 3: 55-65
  • 18 Kellum JM, Kuemmerle JF, O’Dorisio TM et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990; 211: 763-770 discussion 770–771
  • 19 Iannelli A, Anty R, Schneck AS et al. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Surgery 2011; 149: 364-370
  • 20 Bellanger DE, Greenway FL. Laparoscopic sleeve gastrectomy, 529 cases without a leak: short-term results and technical considerations. Obes Surg 2011; 21: 146-150
  • 21 Magee CJ, Barry J, Arumugasamy M et al. Laparoscopic sleeve gastrectomy for high-risk patients: weight loss and comorbidity improvement – short-term results. Obes Surg 2011; 21: 547-550
  • 22 Sanchez-Santos R, Masdevall C, Baltasar A et al. Short- and mid-term outcomes of sleeve gastrectomy for morbid obesity: the experience of the Spanish National Registry. Obes Surg 2009; 19: 1203-1210
  • 23 Pournaras DJ, Le Roux CW. The effect of bariatric surgery on gut hormones that alter appetite. Diabetes Metab 2009; 35: 508-512
  • 24 Karamanakos SN, Vagenas K, Kalfarentzos F et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247: 401-407
  • 25 Korner J, Inabnet W, Febres G et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009; 33: 786-795
  • 26 Langer FB, Reza Hoda MA, Bohdjalian A et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005; 15: 1024-1029
  • 27 Abbatini F, Rizzello M, Casella G et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010; 24: 1005-1010
  • 28 Laville M, Disse E. Bariatric surgery for diabetes treatment: why should we go rapidly to surgery. Diabetes Metab 2009; 35: 562-563
  • 29 Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737
  • 30 Dixon JB, le Roux CW, Rubino F et al. Bariatric surgery for type 2 diabetes. Lancet 2012; 379: 2300-2311
  • 31 Campos GM, Rabl C, Peeva S et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg 2010; 14: 15-23
  • 32 Bose M, Teixeira J, Olivan B et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes 2010; 2: 47-55
  • 33 Morinigo R, Casamitjana R, Delgado S et al. Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care 2007; 30: 1906-1908
  • 34 Miguel GP, Azevedo JL, Gicovate Neto C et al. Glucose homeostasis and weight loss in morbidly obese patients undergoing banded sleeve gastrectomy: a prospective clinical study. Clinics (Sao Paulo) 2009; 64: 1093-1098
  • 35 Nosso G, Angrisani L, Saldalamacchia G et al. Impact of sleeve gastrectomy on weight loss, glucose homeostasis, and comorbidities in severely obese type 2 diabetic subjects. J Obes 2011; 2011: 340867
  • 36 Marantos G, Daskalakis M, Karkavitsas N et al. Changes in Metabolic Profile and Adipoinsular Axis in Morbidly Obese Premenopausal Females Treated with Restrictive Bariatric Surgery. World J Surg 2011;
  • 37 Rizzello M, Abbatini F, Casella G et al. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg 2010; 20: 50-55
  • 38 Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 2008; 60: 470-512
  • 39 Peterli R, Wolnerhanssen B, Peters T et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009; 250: 234-241
  • 40 Korner J, Bessler M, Inabnet W et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 2007; 3: 597-601
  • 41 Rodieux F, Giusti V, D’Alessio DA et al. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 2008; 16: 298-305
  • 42 Zhang F, Strain GW, Lei W et al. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy (LSG). Obes Surg 2011; 21: 305-309
  • 43 Vidal J, Ibarzabal A, Romero F et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008; 18: 1077-1082
  • 44 Wong AT, Chan DC, Armstrong J et al. Effect of laparoscopic sleeve gastrectomy on elevated C-reactive protein and atherogenic dyslipidemia in morbidly obese patients. Clin Biochem 2011; 44: 342-344
  • 45 Zambon S, Romanato G, Sartore G et al. Bariatric surgery improves atherogenic LDL profile by triglyceride reduction. Obes Surg 2009; 19: 190-195
  • 46 Corradini SG, Eramo A, Lubrano C et al. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 2005; 15: 367-377
  • 47 Hady HR, Dadan J, Luba M. The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material. Obes Surg 2012; 22: 13-22
  • 48 Nguyen NT, Varela E, Sabio A et al. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg 2006; 203: 24-29
  • 49 Andreelli F, Amouyal C, Magnan C et al. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?. Diabetes Metab 2009; 35: 499-507
  • 50 Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89: 2595-2600
  • 51 Ocon Breton J, Garcia B, Benito P et al. Effect of gastric bypass on the metabolic syndrome and on cardiovascular risk. Nutr Hosp 2010; 25: 67-71
  • 52 Sovik TT, Irandoust B, Birkeland KI et al. Type 2 diabetes and metabolic syndrome before and after gastric bypass. Tidsskr Nor Laegeforen 2010; 130: 1347-1350
  • 53 Gracia-Solanas JA, Elia M, Aguilella V et al. Metabolic syndrome after bariatric surgery. Results depending on the technique performed. Obes Surg 2011; 21: 179-185
  • 54 Nugent C, Bai C, Elariny H et al. Metabolic syndrome after laparoscopic bariatric surgery. Obes Surg 2008; 18: 1278-1286